Prognosis
U.S. Virus Guidelines Reject Trump-Backed Drug Combination
- Panel made up of 50 doctors, pharmacy experts, researchers
- Potential harm to heart seen from malaria, antibiotic combo
This article is for subscribers only.
A panel of medical experts convened by the U.S. National Institutes of Health recommended against the use of a drug combination touted by President Donald Trump for Covid-19 patients.
The NIH panel, made up of 50 doctors, pharmacy experts and government researchers and officials, specifically recommended against the use of the anti-malaria drug hydroxychloroquine in combination with the antibiotic azithromycin.